University of Leeds

The University of Surrey is a global community of ideas and people, dedicated to life-changing education and research.  We are ambitious and have a bold vision of what we want to achieve - shaping ourselves into one of the best universities in the world, which we are achieving through the talents and endeavour of every employee. Our culture empowers people to achieve this aim and to collectively, and individually, make a real difference. The role Postdoctoral position in computational phonology on "Rational Evolutionary Phonology" Prof Erich Round is seeking qualified applicants for a fully-funded two-year postdoctoral project on “REVOLUPHON: Rational Evolutionary Phonology". This postdoctoral project contributes to the core formal-theoretic and cognitive modelling components in the ERC-selected, UKRI-funded project "Rational Evolutionary Phonology", led by Erich Round in 2024–2029. The position is based at the Surrey Morphology Group at the University of Surrey and provides the opportunity to work in the vibrant and highly collegial research environment for which SMG is renowned. Background REVOLUPHON is an ambitious project in computational cognitive science, cultural evolution and phonological theory, which seeks deeper explanations for human phonology. Though phonological theories are diverse, they contain recurrent axioms and atoms: segments, features, prosodic units, et cetera. We hypothesise that these units of representation are explicable in terms of the interaction of phonetics with resource limitations on human cognition (resource rationality). Separately, recent decades show that phonologies can be reasonably well modelled as optimisation problems, with optimisation imputed to the mind. We hypothesise that apparent optimisation, and its exceptions, arise because phonologies undergo cultural evolution, an optimising process. REVOLUPHON tests these hypotheses through computational modelling of cognition and cultural evolution, to develop new foundations for phonological theory. Responsibilities The candidate will be a core member of a research team focused on achieving the REVOLUPHON project aims and will participate in the broader activities both of the REVOLUPHON group and of the Surrey Morphology Group (SMG). The candidate will have opportunities at SMG to develop their research leadership profile while interacting with world-class researchers. Please refer to the full job description, under ‘Addendum’ for key responsibilities.  About you Suitable candidates trained in theoretical and computational phonology are strongly encouraged to apply. Please refer to the full job description, under ‘Addendum’ for essential and desirable criteria.  The position is full time, and the successful candidate will be required to work on-site at the University of Surrey, Guildford for three days per week. How to apply To apply, please upload a CV along with your application to the University website. You will also be asked some brief questions to help us understand your suitability for the role.  The following documents will be required: CV Contact details for 2 referees. DOI/URL links to up to three relevant works of research. Link to one or more public repositories illustrating coding work. Research statement max. 400 words, describing research interests and experience. Further details Job Description

The Role and Department The Department is one of the UK's leading Mathematics departments with an outstanding reputation in teaching, research, and employability of our students. It has an active programme of internationally recognized research in Pure Mathematics, Applied Mathematics, Statistics and Probability. The research culture is vibrant, with many visitors, seminars, international conferences, and workshops. We aim to provide a supportive and friendly environment with a strong sense of community. The Department currently has 116 permanent members of staff, following a process of significant growth. The Department holds an Athena SWAN Silver award. Athena SWAN is a national initiative that recognises the advancement of gender equality, representation, progression, and success for all in academia. The Department also supports the London Mathematical Society Good Practice Scheme, whose aim is to support mathematics departments to embed equal opportunities for women within their working practices. Durham University is committed to the Concordat to support the career development of researchers. For further information please visit the Research Staff web pages on Applications are invited for a Postdoctoral Research Associate in Mathematics , with a focus on probability. The successful applicant will have demonstrated expertise in probability, statistical mechanics, and/or mathematical physics. The position is funded by an EPSRC NIA grant held by Dr. Tyler Helmuth. The successful applicant will be expected to conduct and disseminate research in collaboration with the PI, and to develop and contribute their own research ideas and experience to the project.

ImmunoViroTherapy Lab at the Faculty of Pharmacy, invites applications for the position of a DOCTORAL RESEARCHER (Assessing the Immunogenic Cell Death Response Induced by Oncolytic Virus Nanoplatforms, DC 8 in MSCA-DN INTRABRAIN) for a full-time position funded for three years. Earliest starting date is in November 2026, with the exact starting date negotiable after selection. Position Description Prof. Vincenzo Cerullo’s lab is seeking a PhD student to investigate the efficacy of nanoplatform encapsulating oncolytic viruses for glioblastoma treatment. The selected PhD candidate will obtain degree at the University of Helsinki. The PhD position consists of studies at Faculty of Pharmacy, University of Helsinki (UH, Finland) and secondments at University of Naples Federico II and University of Rome Tor Vergata, Italy. The position is funded by the Doctoral Network (DN) project “INTRABRAIN” of the Horizon-Marie Skłodowska-Curie Actions (MSCA). The topics of the PhD candidate: investigate the immunogenic cell death (ICD) induced by NanorADV-IL-12, with a particular focus on the release and characterization of nanoparticles and microvesicles (NPs/MVs), including exosomes, extracellular microparticles and apoptotic bodies. Their work will involve analysing tumour cell killing mechanisms and evaluating immune responses in preclinical models. The candidate will collaborate with partner institutions, including University of Naples Federico II and University of Rome Tor Vergata, to study circulating vesicles in plasma, interpret immune-response assay data and gain experience in clinical anticancer therapies. Additionally, they will address technical challenges related to vesicle quantification and immunological monitoring by applying advanced analytical techniques and optimizing experimental protocols. INTRABRAIN Project Description The INTRABRAIN project is an ambitious and highly innovative research and training initiative aimed at revolutionising the treatment of glioblastoma multiforme (GBM) through next-generation cancer immunotherapy. By integrating cutting-edge nanotechnology, virotherapy and immunology, the project focuses on developing novel therapeutic strategies based on polymeric nanoparticles delivering engineered oncolytic adenoviruses encoding the immune-stimulating cytokines. This approach is designed to overcome major clinical challenges such as the blood–brain barrier and tumour-induced immunosuppression, enabling targeted, efficient and less invasive treatment via intranasal delivery. In parallel, INTRABRAIN fosters the training of a new generation of highly skilled doctoral researchers through interdisciplinary, intersectoral and international collaboration, equipping them with advanced scientific and transferable skills. Overall, the project aims not only to advance groundbreaking therapeutic solutions but also to contribute significantly to the future of personalised cancer medicine and biomedical innovation in Europe. Requirements To be a doctoral candidate (DC): You must, at the time of recruitment, be in the first four years (full-time equivalent) of your research career and have not been awarded a doctoral degree. Full-time equivalent research experience is measured from the date when you obtained the degree, which formally entitles you to embark on a doctorate, either in the country in which the degree was obtained or in the country in which the research training is provided, irrespective of whether or not a doctorate was envisaged. Mobility rule: At the time of the recruitment, you must not have resided or carried out your main activity (e.g. work and studies) in Finland for more than 12 months in the 3 years immediately prior to your recruitment. Short stays, such as holidays, are not taken into account. English language: Network fellows (DCs) must demonstrate that their ability to understand and express themselves in both written and spoken English is sufficiently high for them to derive the full benefit from the network training. Master level in Pharmaceutical Sciences, Biotechnology, Biomedical Engineering, Nanotechnology, Nanomedicine, Pharmacy, Pharmaceutical Chemistry and Technology, Molecular Biology or related field, ideally with a multidisciplinary background in nanomedicine, pharmacy and immunology. Right to pursue a doctoral degree Please note that the appointee must obtain the right to pursue a doctoral degree at the Faculty of Pharmacy, University of Helsinki and approval by a suitable doctoral programme (Doctoral Programme in Drug Research - DPDR) by the end of the standard 6-month probationary period of the employment, unless having already existing study right. The research plan and other application material will be prepared together with the PhD supervisor(s) in the beginning of the employment period. Salary and Benefits Salary, pension and terms of employment are in accordance with the requirements from the European Commission related to the MSCA programme. The salary (monthly living allowance) is 3 639,84 € per month before taxes. Additionally, a monthly mobility allowance 546,15 € per month before taxes will be paid. If applicable, a conditional monthly family allowance of 507,69 € per month before taxes is paid.  The guaranteed PhD funding is for 36 months (i.e., funding from the European Commission). In addition to their individual scientific projects, all DCs will benefit from further education, including secondments to University of Naples Federico II and University of Rome Tor Vergata, a variety of training modules as well as transferable skills courses and active participation in workshops and conferences. Standard Finnish pension benefits and occupational health care are provided for the University of Helsinki employees. Read more about the employee benefits at the University of Helsinki and why the University of Helsinki is an excellent career choice: https://www.helsinki.fi/en/about-us/careers. Please also see about relocation support: https://www.helsinki.fi/en/about-us/careers/welcome-finland-information-arriving-staff. How to apply Please submit your application, together with the required attachments AS A SINGLE PDF FILE (in the CV section), through the University of Helsinki Recruitment System via the button Apply now (or Employee login). The application must contain the following documents AS A SINGLE PDF FILE (all provided in English language): INTRABRAIN DC application form (download template here: https://www.intrabrain.eu/s/INTRABRAIN_DC_application-form_final.docx) Curriculum Vitae (max 2 pages) Cover letter (max 1 page): Indicate your motivation to apply for these specific DC position and your skills that are specifically adapted to the chosen topic, providing support evidence to your arguments. Certificate of Master’s Degree (or equivalent) with transcript of records. Proof of English proficiency Contact details of 2 previous supervisors or employers who can give recommendation letters List of publications, if applicable. Manuscript of listed publication, if applicable. Work/research experience certificates, if applicable. All official certificates should be provided in their original European language or associated official English translation for non-European documents. If you are applying for a country different from your native country, an English supplement of the certificates with transcripts should also be provided. Application deadline is on the 28 of May 2026 at 23:59 (Europe/Helsinki time). Further information on: The INTRABRAIN project and the open positions on INTRABRAIN website: https://www.intrabrain.eu/ ImmunoViroTherapy Lab: https://www.helsinki.fi/en/researchgroups/immunovirotherapy-lab The project and position: Professor Vincenzo Cerullo, vincenzo.cerullo(at)helsinki.fi Technical support in applying: HR Specialist Heidi Kauppinen, recruitment(at)helsinki.fi Faculty of Pharmacy: https://www.helsinki.fi/en/faculty-of-pharmacy Viikki Campus: https://www.helsinki.fi/en/about-us/campuses/viikki-campus Working at the University of Helsinki: https://www.helsinki.fi/en/about-us/careers  Support for international staff: https://www.helsinki.fi/en/about-us/careers/welcome-finland-information-arriving-staff and International House Helsinki: https://ihhelsinki.fi Application process to doctoral education at the University of Helsinki: https://www.helsinki.fi/en/admissions-and-education/apply-doctoral-programmes/how-apply-doctoral-programmes (includes also information on accepted ways of proving language skills, when applying to doctoral education; specific research plan and other doctoral application material will be prepared together with the PhD supervisor(s) if selected to this position) This project is funded by the European Union (INTRABRAIN, 101227308). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. The Faculty of Pharmacy at the University of Helsinki provides the highest education in the field of pharmacy offers undergraduate degrees in Bachelor of Science (Pharmacy), Master of Science (Pharmacy), Master of Science, and doctoral degrees (Doctor of Philosophy in Pharmacy, Doctor of Philosophy). offers specialization studies in community and hospital pharmacy, and industrial pharmacy is located at Viikki Campus in Helsinki and provides access to local and national research infrastructures has about 200 employees, out of which about 20 are professors has 900 undergraduate students and 140 doctoral researchers  hosts the multidisciplinary Drug Research Program and the Doctoral Programme in Drug Research  is a European and global leader in sustainable pharmacy is a member of the ULLA consortium (European University Consortium for Pharmaceutical Sciences) Why Finland and Helsinki Finland is a member of the EU, has high-quality and inexpensive childcare, free schooling and tertiary training (also in English), excellent family benefits and healthcare, and is ranked as one of the top countries in the world for expat families. Finland also repeatedly tops the World Happiness Report.  Why Finland is a great place to live and work: https://www.helsinki.fi/en/about-us/careers/why-university-helsinki/why-finland  10 reasons to work in Helsinki: https://www.helsinki.fi/en/about-us/careers/why-university-helsinki/why-helsinki  Welcome to Helsinki: https://welcome.helsinki  A diverse and equitable study and work culture is important to us. That is why we do our best to promote an inclusive university community. We encourage all qualified applicants from diverse backgrounds to apply for our positions. Click this link to read about accessibility and inclusivity at our University. JOIN US TO BUILD A BETTER WORLD – TOGETHER! #HelsinkiUniCareers